Clinical trial initiation
BioNTech and DualityBio Advance Novel HER2-low Breast Cancer Drug to Phase III Trial
Anika Sharma
BioNTech, the renowned name behind the COVID-19 vaccine breakthrough, is venturing into uncharted territory with its licensed antibody-drug conjugate (ADC), ...
